iSpecimen (ISPC) Stock Statistics & Valuation Metrics

iSpecimen has a market cap or net worth of $3.71M. The enterprise value is $2.15M.

iSpecimen has 5,539,345 shares outstanding. The number of shares has decreased by -2.65% in one year.

iSpecimen’s return on equity (ROE) is -3.77 and return on invested capital (ROIC) is -351.30%.

The current PE Ratio of iSpecimen is ―. iSpecimen’s PEG ratio is ―.

In the last 12 months, iSpecimen had revenue of 9.29M and earned -12.50M in profits. Earnings per share was -17.58.

In the last 12 months, operating cash flow was -5.94M and capital expenditures -253.47K, giving a free cash flow of -6.19M billion.

iSpecimen pays an annual dividend of ―, resulting in a dividend yield of ―

iSpecimen upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).

iSpecimen as a current ratio of 0.62, with Debt / Equity ratio of 46.29%

In the past 12 months, iSpecimen has paid 0.00 in taxes.

iSpecimen EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.

iSpecimen has $588.77K in cash and marketable securities with $287.88K in debt, giving a net cash position of -$300.89K billion.

Gross margin is 32.64%, with operating margin of -136.99%, and net profit margin of -134.51%.

The average price target for iSpecimen is $0.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell